research PSS21 GAP ANALYSIS FOR PATIENT-REPORTED OUTCOMES MEASURES FOR ALOPECIA
No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.
Search
forResearch
5 / 183 results 
research PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.
research Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.
research Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
Statins may be linked to reproductive organ conditions, and their risks should be monitored.
research A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.
Community Join
1 / 1000+ resultscommunity New warning by FDA on topical finasteride
The FDA warned that topical finasteride can cause serious side effects like sexual dysfunction and brain fog, similar to oral finasteride. Compounded topical formulations pose additional risks due to lack of regulation.
Clinics
6 / 43 results- 17Hair Loss TreatmentsSK Pro Hair TreatmentSaskatoon, SK · CA
- 66Hair SystemsConsultant Pro Cheveux Dupont INCLavaltrie, QC · CA
- 22SMPHair Loss TreatmentsMaryland Pro ScalpGermantown, MD · US
- 19Hair Loss TreatmentsPLAUKŲ PROVilnius · LT
- 35
TrichologyClínica Pró Saúde CapilarSantana de Parnaíba, SP · BR - 17Hair SystemsEasihair Pro South AfricaCape Town · ZA
Learn
— no results
Experts
— no results